Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia.

Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia.

Item

http://www.wikidata.org/entity/Q37354699

Q37354699

about

Thrombopoietin.Filgrastim improves survival in lethally irradiated nonhuman primates Increased Expression of Connective Tissue Growth Factor (CTGF) in Multiple Organs After Exposure of Non-Human Primates (NHP) to Lethal Doses of Radiation.Hematological changes as prognostic indicators of survival: similarities between Gottingen minipigs, humans, and other large animal models.Preliminary nonclinical toxicity, pharmacokinetics, and pharmacodynamics of ALXN4100TPO, a thrombopoietin receptor agonist, in CD2F1 mice.Thrombopoietin Receptor Agonist Mitigates Hematopoietic Radiation Syndrome and Improves Survival after Whole-Body Ionizing Irradiation Followed by Wound Trauma An anti-apoptotic peptide improves survival in lethal total body irradiation.Civilian nuclear incidents: An overview of historical, medical, and scientific aspects Acute radiation syndrome (ARS) - treatment of the reduced host defense.Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis Myeloid growth factors in oncology.Radiation injury after a nuclear detonation: medical consequences and the need for scarce resources allocation.Establishing a murine model of the hematopoietic syndrome of the acute radiation syndrome Survival efficacy of the PEGylated G-CSFs Maxy-G34 and neulasta in a mouse model of lethal H-ARS, and residual bone marrow damage in treated survivors.History and development of radiation-protective agents.Radiation victim management and the haematologist in the future: time to revisit therapeutic guidelines?The thrombopoietin/MPL pathway in hematopoiesis and leukemogenesis.Granulocyte colony-stimulating factor in the treatment of acute radiation syndrome: a concise review.Combining Pharmacological Countermeasures to Attenuate the Acute Radiation Syndrome-A Concise Review.Nonhuman primates as models for the discovery and development of radiation countermeasures.Regulation of polymorphonuclear cell activation by thrombopoietin.Combined Therapy of Pegylated G-CSF and Alxn4100TPO Improves Survival and Mitigates Acute Radiation Syndrome after Whole-Body Ionizing Irradiation alone and Followed by Wound Trauma.Platelet-like particle production from cultured human megakaryocytic cell line.Role for C-MPL and its ligand thrombopoietin in early hematopoiesis.In vitro and in vivo expansion of stem cell populations.Cytokines in hematopoiesis.An oral HemokineTM, α-methylhydrocinnamate, enhances myeloid and neutrophil recovery following irradiation in vivo.

P2860

Q33330090-F34C40F9-20F9-46AB-AE9B-BD6B6D853C8C Q33390547-6B43BB5E-EA3D-4473-ABB9-08EC88D2E187 Q33390722-AEE1743E-B491-455F-B1DA-7677EF12ECE2 Q33397467-AF7CCFF0-84BB-40F9-B51B-DAE6B0D6C2EB Q33406871-F5235702-D7A5-4724-9BCA-46FDE2C6D35D Q33440984-3C45ACFF-1C19-4955-93A4-BC0184CF4315 Q33789426-934C1B0D-17CF-4D2B-83AC-9F11EBC9F556 Q35093930-2BA5C2CA-FF42-45EA-8D9A-E2E11612B961 Q35739584-FDFE3B44-5624-4B49-9144-F3E9972EB80B Q36144024-8D82FFA7-299A-4A08-972F-3075B0ABE0DB Q36181140-62FE31C2-448B-49EA-A54C-3F074A097141 Q36813353-54FE8423-80A5-431B-9E02-8348C6730DC2 Q37094589-20BB7C54-0048-4BC4-B180-918BD5E02969 Q37349188-C1E9F37C-42E3-489E-8B4B-1ECFDD1CF03F Q37532178-D57F8510-E9B4-49C8-BBBE-3791D9A0C232 Q37769565-32DCB009-8EFD-4DC8-AB13-F8AA3CAE71AF Q37848274-2B69A4F5-96D1-4126-9D4E-3C0B056BD0A3 Q38205372-420F9CCD-7784-49B0-9818-31EFA3A8E60D Q38769190-C78099C4-C8AC-4F59-BB1C-53A7C159E4B9 Q39261890-5550B245-E625-448F-9B78-8C102623D75E Q39781875-ADD686CD-8972-4B1F-B98C-6214ACD1D7A3 Q40076209-110C021C-3630-4ABB-A1A9-30BF68EB75B3 Q40989773-2B3B65BA-B537-4950-86CB-08E67A4AE34E Q41719619-F9C28A6F-3B2B-43C4-B75A-9D1F30E23E47 Q47686606-20E1002D-D6A9-4C1C-9ED2-39CE18863D6A Q47912530-83BC71B6-7464-4022-AFB4-BD1209EE0A49 Q52820544-7EFCB384-9D3E-4BAF-A0D3-05393A4FEA83

P2860

Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia.

Item

http://www.wikidata.org/entity/Q37354699

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 1996

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs